Work

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/sj.npp.1300260

Authors: Mark S Kramer, Andrew Winokur, Jeffrey Kelsey, Sheldon H Preskorn, Anthony J Rothschild, Duane Snavely, Kalyan Ghosh, William A Ball, Scott A Reines, Dennis Munjack, Jeffrey T Apter, Lynn Cunningham, Mitchel Kling, Mohammed Bari, Albert Getson, Yih Lee

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), UConn Health, Emory University, University of Kansas, University of Massachusetts Chan Medical School, Princeton University, Baltimore VA Medical Center, VA Maryland Health Care System

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045030807

FWCI: 13.31

Cites: 60

Cited by: 254

Related to: 10